In Depth 15 May 2024
Drugs for IgA nephropathy on the rise in the clinic
As we observed IgA Nephropathy Awareness Day on May 14th, let us take a look at ongoing clinical trials for drugs that aim to make patient lives better.
About
Having completed a master’s programme in International Journalism from Cardiff University in 2022, I have written about various subjects including culture, politics, social justice, mental health, LGBTQ+ issues and gender. My undergraduate degree in life sciences has equipped me to explore my passion for reporting on health, science and the environment. When I’m not transcribing interviews and fretting about deadlines, I like to spend my time reading, watching movies, and making lousy mixtapes for a potential side career in rap music.
Articles by Roohi Mariam Peter
In Depth 9 May 2024
BTK inhibitors: can these drugs tackle cancer and autoimmunity?
BTK inhibitors were first approved over a decade ago to treat a rare blood cancer. Now, they are in the running to treat a host of autoimmune diseases.
In Depth 6 May 2024
The rise of Spain: A key player in global clinical trials
Spain has climbed the research and development ladder in recent years, and has made it to the top as one of the world leaders in the life science industry.
In Depth 2 May 2024
New treatments for cystic fibrosis: boosting life expectancy
Discover how cystic fibrosis treatments are extending life expectancy, with recent advancements set to increase it by 75% by next year.
Best in Biotech 2 May 2024
Eight monoclonal antibody biotechs making strides in the clinic
In this article, we take a look at eight biotechs advancing their monoclonal antibodies through the clinic that have made the news in recent times.
Expert Advice 26 Apr 2024
Biotech career: What it’s really like being a research assistant
Labiotech spoke to Elina Kuznecova, a research assistant at the University of Oxford, to find out about what the role of a research assistant entails.
ADVERTISEMENT
ADVERTISEMENT
In Depth 24 Apr 2024
Overcoming toxicities: are IL-2 smart cytokines the next big thing?
A more advanced form of IL-2 cytokine therapy called IL-2 smart cytokines could overcome side effects, and shake up cancer care as we know it.
Best in Biotech 16 Apr 2024
Seven biotech companies climbing their way up in Colorado
We take a look at seven biotechs in Colorado that have secured funding in recent years, to make headway with their pipeline candidates.
In Depth 15 Apr 2024
Does the FDA need to tighten its grip on drug trials in the U.S.?
Studies suggest that the FDA has been less rigorous with its drug approval standards. We looked at the current state of the approval process.
Best in Biotech 11 Apr 2024
Seven companies leading the mRNA revolution in biotechnology
Here are seven mRNA biotechs that have raised funds in recent years to push their candidates ahead through preclinical and clinical trials.
Best in Biotech 9 Apr 2024
Eight biotech companies you should know about in Austria
Here are eight Austrian biotech companies that have received funding in recent years to propel their pioneering innovations forward.
Best in Biotech 28 Mar 2024
Are these T cell receptor (TCR) therapy companies on your radar?
As biotechs step up in the TCR therapy space, here are seven companies with promising candidates in the clinic.
ADVERTISEMENT
